Please use this identifier to cite or link to this item:
Title: IL-4 in tuberculosis: Implications for vaccine design
Authors: Rook, G.A.W.
Hernandez-Pando, R.
Dheda, K.
Teng Seah, G. 
Issue Date: Sep-2004
Citation: Rook, G.A.W., Hernandez-Pando, R., Dheda, K., Teng Seah, G. (2004-09). IL-4 in tuberculosis: Implications for vaccine design. Trends in Immunology 25 (9) : 483-488. ScholarBank@NUS Repository.
Abstract: Current attempts to find a vaccine for tuberculosis (TB) are based on the assumption that it must drive a Th1 response. We review the evidence that progressive disease might not be due to absence of Th1, but rather to the subversive effect of an unusual Th2-like response, involving interleukin-4 (IL-4) and IL-4δ2. This Th2-like response can impair bactericidal function and lead to toxicity of tumour necrosis factor-α (TNF-α) and to pulmonary fibrosis. If this is important, effective vaccines will need to suppress pre-existing Th2-like activity. Such vaccines are feasible and are active therapeutically in mouse TB.
Source Title: Trends in Immunology
ISSN: 14714906
DOI: 10.1016/
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.